Pfizer licenses plasmid DNA-alternative tech from Touchlight
Touchlight will license its patented doggybone DNA (dbDNA) technology to Pfizer for the manufacture of mRNA therapeutics, vaccines, and gene therapies. The agreement will provide Pfizer with access to Touchlight’s dbDNA patent rights, which the firm said will allow it to rapidly produce DNA tem ...
Once the expansion is complete the manufacturing capacity in Halle, Germany will be more than tripled, says Wacker.
The expansion, which sees ...- AstraZeneca says it will bolster its hematology pipeline through the acquisition of TeneoTwo and its clinical-stage T-cell engager, TNB-486.
...
- Terumo Blood and Cell Technologies has partnered with GenCure (a subsidiary of BioBridge Global) to expand and combine cell and gene therapy prod ...
- The Albany College of Pharmacy and Health Sciences (ACPHS) says a newly acquired medical and life sciences facility will allow it to create a hub ...
Recent Tweets
-
RT @Dan5tanton: Two co-founders of Taiwanese firm JHL Biotech were sentenced last month for plotting to steal trade secrets from Ge… https://t.co/0iclK4yS7h
3 months ago
-
RT @frankvinluan: Shutdown comes 8 months after FDA sent a warning letter about a #microbiome metabolic therapy the #biotech was test… https://t.co/FgtTS54Yj0
3 months ago
-
RT @Dan5tanton: A win for CDMO Catalent as it further strengthens its global network, but potentially a loss to the UK taxpayer, wh… https://t.co/Ex9CNdbcf0
3 months ago
-
RT @Dan5tanton: The US Department of Health and Human Services #HHS has terminated a long-term #CDMO partnership with Emergent BioS… https://t.co/bAbKWb3uqQ
8 months ago
